Target intelligence / Profile preview

Eimeria nuclear division machinery

Molecular classification
Protein complex, Cytoskeletal proteins, Enzymes, Other
01

Overview

The Eimeria nuclear division machinery encompasses the specialized proteins and structural elements, such as spindle pole bodies and microtubules, that facilitate the rapid asexual replication of Eimeria parasites during schizogony [1]. This process is characterized by multiple rounds of nuclear division within a single cell (the schizont) before cytokinesis occurs to produce numerous merozoites [2]. Because Eimeria species are the causative agents of coccidiosis in poultry and livestock, this machinery is a primary target for chemotherapeutic intervention [3]. Anticoccidial drugs like Diclazuril and Toltrazuril are known to disrupt these division processes, leading to the swelling of organelles and the eventual degeneration of the parasite's intracellular stages [4]. The unique nature of "closed mitosis" in these apicomplexan parasites provides a therapeutic window to target the parasite without significantly affecting the host's cellular division [5]. Understanding this machinery is crucial for developing new treatments to combat widespread drug resistance in agricultural settings [6].

Other names
Schizogony mitotic apparatusEimeria cell cycle machineryMerogony nuclear division complexApicomplexan mitotic spindle
02

Mechanism of action

Inhibition of nuclear division and daughter cell formation during schizogony and gametogony by disrupting metabolic pathways or structural components of the mitotic apparatus.

03

Biological functions

Cell cycleCell proliferationDNA replicationMitosis
04

Disease associations

InfectionCoccidiosis
05

Safety considerations

Development of drug resistancePotential for host cell toxicity if targeting conserved eukaryotic mitotic proteinsEnvironmental persistence of metabolites
06

Interacting drugs

Diclazuril

2 more in the full profile.

07

Biomarkers

Oocyst per gram (OPG) countLesion scoreParasite DNA load (qPCR)

Beyond the preview

Go deeper on Eimeria nuclear division machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eimeria nuclear division machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call